Tumor suppressor gene mutations trigger immune activation in early oral cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Oct-2026 09:17 ET (29-Oct-2026 13:17 GMT/UTC)
Genetic alterations in TP53 and CDKN2A can shape the immune response during early oral cancer development. Researchers from Tokushima University reveal that imbalanced p53–RB signaling activated the cGAS–STING pathway, allowing increased inflammatory signaling and infiltration of cytotoxic T cells and natural killer cells. This immune response was associated with delayed progression to invasive oral cancer. The findings highlight how specific tumor-suppressor alterations can influence antitumor immunity and progression during early carcinogenesis.
A small number of random genetic mutations cause simple RNA droplets to transform into cell-like structures. In this process, they form cavities, can move and are able to take up cargo. This has been demonstrated through research using nanostructures based on ribonucleic acid led by Prof. Dr. Kerstin Göpfrich at the Center for Molecular Biology of Heidelberg University (ZMBH) in cooperation with experts from the German Cancer Research Center and the University of Augsburg. Just a few molecular changes are enough to trigger these complex processes in very simple synthetic cells – a principle that the researchers also hope to harness for medical applications.
Researchers at The University of Texas MD Anderson Cancer Center and collaborating institutions in Texas developed an artificial intelligence (AI) model that helps explain how immune cells find their way to specific locations in the body and why they avoid others. The findings could help scientists better understand cancer, autoimmune diseases and treatment response.
Research at The Ohio State University Wexner Medical Center finds stress during pregnancy may change how the placenta sends messages to the fetus. These changes may help explain how pregnancy stress can affect early brain development. Researchers hope to eventually identify a therapy to stop the transmission of stress.
Researchers have identified a protein not previously found in the placenta that plays a role in infant vascular development and potentially affects maternal health. Their discovery is described in a new article published in Angiogenesis.